Receptor tyrosine kinases have become important therapeutic targets because of their involvement in diseases, including cancer. Kinase domains, which are soluble and easily purified, have found widespread use in enzyme inhibitor assays, but these domains do not exhibit full function because they are isolated from the membrane. To address this shortcoming, the authors developed a simple method to restore biologically relevant function by assembling kinase domains on a nanometer-scale template, which imitates the membrane surface. Autophosphorylation of template-assembled tyrosine kinase domains from the insulin, EphB2, and Tie2 receptors led to substantially larger phosphorylation levels compared with domains assayed under conventional conditions. Template-directed assembly increased the total substrate phosphorylation of the insulin and EphB2 receptor kinase domains as much as 60-fold and 15-fold, respectively. In contrast, substrate phosphorylation by template-assembled Tie2 was much lower than conventional conditions. The lower activity observed with the template is more biologically relevant because autophosphorylation of Tie2 is self-inhibitory. These results, as well as the underlying similarity between the organization of template-assembled and natural membrane signaling environments, suggest that template-directed assembly of signaling proteins will provide widespread benefit to basic and applied signal transduction research, especially drug discovery. (Journal of Biomolecular Screening 2008:810-816) 
INTRODUCTION
R ECEPTOR TYROSINE KINASES (RTKS) have become important targets of drug discovery efforts because of their roles in cancer and other diseases. 1 One significant challenge that cancer researchers face is the involvement of RTKs in multiple, overlapping, and branched signaling pathways, which makes it difficult to identify individual functions. 2 Moreover, as transmembrane or membrane-associated proteins, intact RTKs are notoriously difficult to isolate and study. For structural and mechanistic studies, recombinant kinase domains have been produced as soluble fragments to simplify purification. In drug discovery, the effort to find specific small-molecule inhibitors has focused almost exclusively on inhibitors that target the adenosine triphosphate (ATP) binding site, the substrate binding site, or both; these sites reside in the cytoplasmic tyrosine kinase domain. Although recombinant kinase domains are easily handled and are amenable to high-throughput screens for specific inhibitors of enzyme activity, the soluble fragments lack the full function of intact receptors in large part because they are no longer associated with the membrane and, therefore, do not form the necessary interactions for complete pathway assembly and function. Also, it has been noted that the use of soluble fragments frequently produces misleading results. 3 Despite these concerns, soluble catalytic domains derived from RTKs are still widely used in research and drug discovery. Therefore, methods to improve the functional properties of these protein fragments for research and drug discovery efforts are required.
Template-directed assembly (TDA) of signaling proteins was created to place the soluble domains derived from transmembrane receptors, as well as the other signaling proteins that are normally associated with the membrane, back into a membrane environment. With the use of a simple add-in template reagent, TDA imitates the membrane environment in vitro without detergents; TDA generates assays with more biologically relevant properties.
As a means to reconstitute large portions of signaling pathways, TDA was first applied by Shrout et al. 4 to signaling proteins purified from the bacterial chemotaxis system. TDA has proven effective for assembling the "receptosome" from the bacterial chemotaxis system, which consists of 4 proteins: the cytoplasmic domain from the aspartate receptor (Tar-CD); the histidine kinase, CheA; the adaptor protein, CheW; and the response regulator protein, CheY. 4, 5 Tar-CD is not an enzyme, but along with CheW, Tar-CD recruits CheA and regulates the phosphotransfer activity of CheA toward CheY. Electron microscopic images of the surface-assembled complexes of Tar-CD, CheW, and CheA resemble the receptor arrays that occur in cells. 5 Since the completion of this work, TDA has been used successfully to restore the biochemical activity in a variety of systems. [6] [7] [8] These studies demonstrate the principal advantage of template-directed assembly: to simply and effectively assemble functional signaling complexes of membrane-associated proteins.
To demonstrate the utility of TDA to signaling pathways of interest to drug discovery efforts, we compared the activities of commercially available histidine-tagged RTK fragments measured under template-assembled conditions with conventional assay conditions (without template). The receptor kinases were selected for their role in human disease. In addition, these proteins are often found in the panels of enzymes offered as commercial kinase profiling services.
Template-directed assembly regenerates functional interactions
In the cell, RTKs are confined to 2 dimensions, where the large local concentration of receptors promotes clustering. The interaction strengths among receptors are "tuned" to this environment so that intact receptors can engage in dimerization equilibria and form higher order oligomers that are relevant for signaling. 9, 10 Also, receptor clusters act as scaffolds for adaptor proteins and downstream signaling proteins. The membrane-associated complexes that assemble can exhibit cooperative and allosteric phenomena; these organizational features are common to many signaling pathways. Receptor domain fragments released from the membrane-to solution-are in an unnatural environment, but these recombinant fragments in solution are the current "conventional" form used in drug discovery enzyme assays. TDA regenerates the special features of the membrane environment, including (1) the restriction of motion to 2 dimensions, (2) an increased local concentration that accompanies the reduction in dimensionality, and (3) the facilitation of scaffolding interactions, which lead to the formation of protein signaling complexes. We created TDA for signaling proteins that require membrane association and/or the membrane environment for full function, and we expect the approach can be used to assemble essential portions of signaling cascades in vitro with purified components for new assays of signaling function. Figure 1 illustrates how TDA facilitates functional interactions among receptor tyrosine kinase (TK) domains, which are not present in the conventional assay format. In the cell, the orientation and spatial arrangement of kinase domains are regulated by the membrane (Fig. 1a) . For example, regulated interactions among cytoplasmic domain dimers are necessary for transphosphorylation and stimulated substrate activity. In some cases, signal enhancement may occur via higher order oligomerization. 9 These interactions among TK domains are not present without the template (Fig.  1b) , and interactions with adaptor proteins and downstream signaling elements are similarly ineffective. Figure 1c depicts the patentpending approach used by P.A. Technologies to assemble TK domains in an environment that imitates the membrane surface. TDA technology also can be used to assemble downstream signaling proteins. P.A. Tech's use of TDA employs a proprietary, lipidbased, nanometer-sized template that binds histidine-tagged TK domains with relatively high affinity, thereby orienting the domains on the membrane surface in much the same way these proteins are assembled in the cell membrane. The greatest difference between most receptors in the cell ( Fig. 1a ) and templateassembled cytoplasmic domains ( Fig. 1c) is an ectodomain that binds ligand. The ectodomains of most RTKs provide a regulatory constraint that is released on ligand binding, at which time the cytoplasmic domains are poised to undergo trans-autophosphorylation. 10 Template-assembled TK domains, like membrane-associated cytoplasmic domains expressed in cells, 11 are not regulated by an ectodomain, and in both cases, the membrane-bound TK domains are more likely to be constitutively active.
All membrane-based signaling systems have the same organizing principles, regardless of the origin of the cell, 12 so it is plausible to expect that TDA will improve the activity and function of eukaryotic signaling proteins. To demonstrate the general utility of TDA with human signaling proteins, we measured the autophosphorylation and substrate phosphorylation activities of commercially available TK domains in the template-assembled format and compared template-enabled activities with activities measured under conventional assay conditions. Autophosphorylation was greatly improved for the following receptor TK domains: insulin receptor (InsR), EphB2 receptor (EphB2), and Tie2 receptor (Tie2). Substrate phosphorylation increased for template-assembled InsR and EphB2 TKs, yet decreased for the template-assembled Tie2 TK domain. Published data provide evidence that autophosphorylation inhibits Tie2. 13 Therefore, our results demonstrate that the more biologically relevant function is observed with templateassembled Tie2 TK domains compared with Tie2 assayed under conventional conditions.
MATERIALS AND METHODS

Preparation of template
Template material was prepared and characterized by published methods 5 with proprietary improvements in template composition to lengthen shelf life and performance. Dynamic light scattering was used to determine the hydrodynamic radius (~100 nm). Template was stored at 4°C.
Phosphorylation assays
Phosphorylation assays were conducted using TK domains of InsR (#14-466, residues 1005-1310), EphB2 (#14-553, residues 560-end), and Tie2 (#14-540, residues 771-end) purchased from Upstate (now a part of Millipore, Billerica, MA). Assays measured the 32 P-labeled phosphate incorporation according to manufacturer protocols unless indicated otherwise. Samples were incubated with template for 10 min at 30°C (conventional assay conditions lacked template) with 100 μM ATP added. InsR buffer contained 50 mM Tris-HCl (pH 7.2), 250 μM Axltide substrate (Upstate #12-516), 13.5 mM MgCl 2 , 90 μM ATP, and 0.1 mM EGTA in a total volume of 25 μL. EphB2 and Tie2 buffer contained 10 mM MOPS (pH 7.2), 0.1 mg/mL poly(Glu 4 Tyr) (P7244, Sigma, St. Louis, MO), 13.5 mM MgCl 2 , 90 μM ATP, and 0.1 mM EGTA in a total volume of 25 μL. The assay buffers sometimes included MnCl 2 , as noted. The molar concentration of template particles, when added, was 1/10,000 the molar enzyme concentration. Phosphate incorporation was measured after a 10-min reaction time with 20-μL aliquots spotted on filter paper, rinsed in 0.75% phosphoric acid (4×), and finally rinsed in acetone. 32 P-phosphate content was determined by scintillation counting using a Beckman LS 1801 in 5 mL of scintillant (Ultima Gold, PerkinElmer, Waltham, MA). The remaining sample was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography (not shown) to verify the specific addition of phosphate to the tyrosine kinase domain fragment.
Time-resolved fluorescence resonance energy transfer assays
InsR and EphB2 were assayed for activity using the timeresolved fluorescence resonance energy transfer (TR-FRET) Screening Express Kit (R8160) by Molecular Devices (Sunnyvale, CA) according to the protocol described in the product insert. reaction volume of 20 μL. Reactions were quenched following a 1-h incubation at room temperature by addition of 60 μL binding buffer (60% Binding Buffer A, 40% Binding Buffer B, 1:600 dilution of Progressive Binding Reagent, and Tb-donor diluted 1:400). A Spectramax M5 plate reader was used to read the TR-FRET signal following a 2-hour incubation after the addition of the binding buffer. Background-corrected TR-FRET was calculated using the TR-FRET calculator by Molecular Devices, available for download at www.moleculardevices.com. Experiments were completed in triplicate with average values reported and standard deviation indicated by error bars.
RESULTS AND DISCUSSION
Insulin receptor
The insulin receptor is an α 2 β 2 heterotetramer that becomes activated via transphosphorylation upon binding insulin. The multiple phosphorylation sites in the cytoplasmic domain of the β-subunit regulate kinase activity and recruit downstream signaling proteins such as IRS1 and Shc via interactions with SH2 domains. 14, 15 The results in Figure 2 demonstrate the dramatic improvement in activity that TDA can generate. InsR autophosphorylation, measured in the absence of peptide substrate, was 70-fold larger in samples with template present than in samples in the standard assay buffer, which contained 10 mM MnCl 2 (Fig. 2, left) . Autophosphorylation was not detected in samples lacking template and Mn 2+ . Template-assembled samples did not require addition of Mn 2+ for activity. Mn 2+ is commonly added to improve activity of TK domains, but the mechanism of enhancement is poorly understood, and (nonphysiological) large concentrations often are necessary. (In the absence of template, Mn 2+ was added to improve activity in solution.) By contrast, TDA improves the kinase activity in an understandable and biologically relevant manner, where histidine-tagged TK domains bound to the template surface are properly oriented. The fluid nature of the template, like a cell membrane, allows for the favorable and dynamic interactions among domains, producing significant increases in InsR TK domain autophosphorylation, activation, and substrate phosphorylation. In this respect, the template-assembled InsR TK domain behaves like a cloned membrane-associated InsR β-subunit that lacks the extracellular ligand-binding domain. When White and colleagues 11 expressed such a clone in cells, the membraneassociated cytoplasmic domain was constitutively active because the inhibitory influence imposed by the extracellular domain was missing.
Total phosphate incorporation (autophosphorylation plus substrate phosphorylation) was also considerably better in the presence of template (Fig. 2, right) . Phosphorylation in the presence of template (no Mn 2+ ) was improved >30-fold relative to "optimized" conventional assay conditions in a buffer with 10 mM MnCl 2 . In buffers without Mn 2+ , the difference in activity was even greater (60 fold or more, data not shown).
EphB2 and Tie2
Kinase activities of TK domains derived from the EphB2 and Tie2 receptors were measured in the presence and absence of template to further demonstrate the general applicability and benefits of TDA. The autophosphorylation data plotted in Figure 3 demonstrate that TDA improves activity substantially of both the EphB2 (Fig. 3a) and Tie2 (Fig. 3c ) TK domains. The total phosphorylation of template-assembled EphB2 also improved substantially (Fig. 3b) . In contrast to results obtained with the InsR and EphB2 TK domains, the total phosphorylation observed with template-assembled Tie2 TK domains was substantially lower than samples without template present (Fig. 3c) . Preincubation of template-assembled Tie2 domains with ATP further reduced the amount of substrate phosphorylation observed in a 10-min assay from ~3-fold ( Fig. 3c) to >5-fold (not shown). Interestingly, a structural analysis of the Tie2 TK domain suggests that autophosphorylation of Tie2 is inhibitory. 13 That we observe significantly less substrate phosphorylation with the autophosphorylated template-assembled Tie2 TK domain strongly suggests that TDA facilitates assembly of a more biologically relevant signaling unit in a simple in vitro assay format.
FIG. 2.
Template-directed assembly (TDA) increases insulin receptor kinase domain phosphorylation and activity. The InsR tyrosine kinase (TK) domain (100 nM) was assayed for autophosphorylation and total (auto plus substrate) phosphorylation, as described in Materials and Methods. Template means the template was present at 1/10,000 the molar concentration of the TK domain. Solution assays include 10 mM MnCl 2 , which are "optimized" solution conditions. The addition of Mn 2+ to template-assembled InsR TK domains modestly decreased activity (~10% to 60% with 2 to 10 mM Mn 2+ , respectively; data not shown). Still, these activities were substantially greater than the kinase samples without template under the same conditions. The level of autophosphorylation measured with template present corresponds to ~3 phosphates per TK domain, which was estimated from the specific activity of 32 P-phosphate, and an assumption of 100% capture of the InsR TK domain on the filter. Data are reported as an average of 3 measurements with error bars representing standard deviation.
High-throughput screening-compatible technology
To demonstrate the compatibility of TDA reagents with high-throughput screening (HTS)-accepted technology, we used IMAP TR-FRET to measure phosphorylation of a fluorescent-labeled peptide by template-assembled InsR and EphB2. Results presented in Figure 4 show that templateassembled enzymes outperform the standard solution-based enzymes. To demonstrate that TDA is amenable for use with these industry-accepted methods, we followed the manufacturers' assay protocol; these assays were run in the presence of 2 mM MnCl 2 . In addition, we have determined that TDA is compatible with the Caliper LC-3000 (data not shown) and thus expect that the template will be compatible with many HTS readout methods in current use. To this end, we are currently testing TDA technology with a number of these readout technologies. . 4) , and Tie2 data are reported as an average of 3 measurements with error bars representing standard deviation.
FIG. 4.
Time-resolved fluorescence resonance energy transfer (TR-FRET). InsR and EphB2 activity was assayed at the indicated concentrations in the presence and absence of template material (added at 1/10,000 [enzyme]). The signals generated with a calibrator peptide (R7159), analyzed in buffers identical to the respective assays, were 3900 at 1 μM peptide and 2300 at 500 nM peptide.
Applications of template-directed assembly to research and drug discovery
TDA can facilitate the in vitro study of complete, specific, signaling pathway branches and provides a biologically relevant platform for the assembly of cloned soluble TK domains and/or other membrane-associated proteins that require the membrane scaffold for assembly and function. The published studies that use TDA to regenerate the bacterial signaling pathway from Escherichia coli support our belief that similar success will be achieved with cancer-related eukaryotic pathways because all membrane-associated signaling pathways are subject to the same organizing principles. This belief is supported by the investigations of several groups that have used template assembly to reconstitute mammalian protein complexes, thereby confirming the generality of this approach. [6] [7] [8] 16, 17 Transmembrane cell signaling represents a complex and essential field of study. A significant fraction (>50%) of the drug targets currently in development are proteins involved in signal transduction pathways. A detailed understanding of these pathways is essential for developing more effective drugs and therapeutics. TDA provides a significant improvement over the current state of the art. The TDA reagent is compatible with simple radiometric assays as well as FRET-based and Lab-ona-Chip high-throughput assay formats. Figure 5 presents our vision of the novel in vitro signaling assays that are made possible by template-directed assembly. In Figure 1c , we presented the simplest level of assembly. The results presented earlier with the InsR, EphB2, and Tie2 TK domains clearly demonstrate the advantages of this method. Figure 5a illustrates the concept of pathway assembly using TDA. Teams of signaling enzymes can now be assembled with this simple in vitro approach to allow detailed analyses of multiprotein signaling complexes and the properties that emerge only in the context of these assemblies (e.g., cooperative, competitive, and allosteric phenomena). The published results obtained with the bacterial chemotaxis signaling pathway provide the proof of principle for the feasibility of this approach (reviewed in Montefusco et al. 5 ). The strong parallels in the organization of signaling pathways in all cells provide us with the expectation that similar phenomena can be probed in eukaryotic signaling pathways. For example, we expect that it will be possible to use TDA to assemble insulin receptor TK domains with pathway-specific scaffolding domains and downstream signaling proteins such as IRS1, Shc, and Grb2. We anticipate that the assembled complexes will reveal new properties that could not be studied without the use of TDA. Finally, Figure 5b depicts the possible applications to in vitro screening of these signaling complexes. TDA signaling complexes will allow researchers to conduct HTS campaigns of targets that are now only accessible in cell-based assays. It is plausible to expect that TDA-enabled screens can be conducted on large scales at reasonable costs (much lower than cell-based assays) for inhibitors of protein-protein interaction and new sites other than the widely interrogated ATP and substrate binding sites. As our understanding of the interactions among membraneassociated proteins grows, the need for TDA to provide an accurate assessment of function and activity inhibition will become more desirable. 9
FIG. 5.
Applications of template-directed assembly (TDA) to drug discovery. TDA will benefit drug discovery research in many ways, including the ability to restore full function to tyrosine kinase (TK) domain fragments. (a) Assemble cascades with downstream signaling proteins. (b) Use the assembled signaling cascades to screen for new classes of inhibitors.
